The unavailability of albumin-to-creatinine ratio data in patients’ records in our healthcare facilities, where this test is rarely conducted, may potentially result in an underestimation of the actual prevalence of CKD within our study sample. The gene discussed is ALB; the disease is chronic kidney disease.